Key result
Low-dose dobutamine radionuclide ventriculography was more sensitive for the identification of viable myocardium compared to 201Tl-SPECT (91.4% vs 74.2%).
Why the study?
Does low-dose dobutamine radionuclide ventriculography improve the identification of viable myocardium compared to 201Tl-SPECT in patients with ischemic heart disease?
Observational (n=54)
Yes
Does low-dose dobutamine radionuclide ventriculography improve the identification of viable myocardium compared to 201Tl-SPECT in patients with ischemic heart disease?
Absolute Event Rate: 91.4% vs 74.2%
Low-dose dobutamine radionuclide ventriculography provides higher sensitivity but lower specificity than 201Tl-SPECT for identifying viable myocardium in patients with ischemic heart disease.
May support viability assessment in ischemic heart disease; leaves open need for prospective outcome trials before practice change.
BACKGROUND: It is important to distinguish viable myocardium from necrotic tissue in order to decide upon therapy in patients with ischemic heart disease. HYPOTHESIS: We verified the hypothesis that quantitative analysis of regional left ventricular function using low-dose dobutamine radionuclide ventriculography (RNV) can sensitively predict myocardial viability and compared its usefulness with thallium-201 (201Tl) single-photon emission computed tomography (201Tl-SPECT). METHODS: Radionuclide ventriculography at rest and during low-dose dobutamine infusion (5 micrograms/kg/min), 201Tl-SPECT, and coronary angiography were performed in 51 subjects with severe ischemia-related stenosis of coronary arteries and 3 subjects without coronary artery disease. 201Tl uptake was assessed as normal (control), low perfusion (LP), or defect. We compared the response of regional function to dobutamine with the regional 201Tl uptake. The accuracy of both methods for identifying viable myocardium was investigated in 17 patients who underwent successful coronary revascularization, with a resulting improvement in wall motion. RESULTS: The increase in regional ejection fraction (delta r-EF) in response to dobutamine was significantly greater in the control (12 +/- 6%) and LP (16 +/- 11%) regions than in the defect (5 +/- 10%) regions. The increase in one-third regional ejection fraction (delta r-1/3EF) was also significantly higher in the control (14 +/- 7%) and LP (10 +/- 8%) regions than in the defect regions (5 +/- 6%). We defined myocardial viability as a delta r-EF > 5% or a delta r-1/3EF > 2%. The sensitivity and specificity of the delta r-EF for identification of myocardial viability were 91.4 and 55.5%, respectively. The sensitivity and specificity of the delta r-1/3EF were 91.4 and 66.6%, respectively; the corresponding values for 201Tl SPECT were 74.2 and 77.8%. CONCLUSION: Low-dose dobutamine RNV with quantitative analysis of regional left ventricular function was more sensitive for identification of viable myocardium than 201Tl-SPECT.
No takes yet. Share an insight, caveat, or question.
Takeyasu et al. (2000) conducted an observational in Ischemic heart disease (n=54). Low-dose dobutamine radionuclide ventriculography vs. Thallium-201 single-photon emission computed tomography (201Tl-SPECT) was evaluated on Sensitivity for identification of myocardial viability. Low-dose dobutamine radionuclide ventriculography was more sensitive for the identification of viable myocardium compared to 201Tl-SPECT (91.4% vs 74.2%).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: